China's Sodium Oligomannate(甘露特钠胶囊):Pictures,Uses,Dosage,Side Effects,Warnings-SEAGULL HEALTH

Introduction of Sodium Oligomannate

Sodium Oligomannate Capsules is the world’s first Alzheimer’s disease drug targeting the gut-brain axis. Its R&D was backed by national key science and technology programs such as the National 863 Program and Major New Drug Creation Program, and it got NMPA priority review approval for marketing in 2019.

Indications

Sodium Oligomannate is indicated for the treatment of Alzheimer’s disease (AD), primarily in patients with mild to moderate AD, to improve cognitive function. Although its exact mechanism of action has not been fully elucidated, studies have demonstrated that it can alleviate disease symptoms by modulating brain function.

Overview

Generic Name

Sodium Oligomannate Capsules,甘露特钠胶囊

Brand Name

九期一

Drug Type

Rx Drug

Approval No.

国药准字H20190031

Active Ingredient

Sodium Oligomannate

Dosage Form

0.15g*42capsules

Specification

Capsules

Description

The contents of the capsule are an off-white to pale yellow powder or granules.

Expiry Date

24 months

Manufacturer

Shanghai Greenvalley Pharmaceutical Co., Ltd.

Storage

Store sealed at or below 25°C.

Dosage and Administration

Administer orally, 3 capsules (450mg total) twice daily. The drug may be taken on an empty stomach or with food; neither administration method impairs the drug efficacy.

Important Note: Drug products with the same name manufactured by different pharmaceutical manufacturers may have discrepancies in package insert information. If inconsistencies are found between the content of the drug package insert and the description herein, consult the attending physician or a professional pharmacist for confirmation immediately.

Contraindications

This medicinal product is contraindicated in patients with hypersensitivity to any component of it. Severe hypersensitivity reactions may occur in such patients following administration.

Adverse Reactions

The following adverse reactions may occur during administration:

Serious reactions: Pneumonia (pulmonary infection) may develop.

Common reactions: Cardiac arrhythmia (e.g., tachycardia or bradycardia) may occur.

Uncommon reactions: Hepatic impairment, hypotension, sudden convulsions and other conditions may arise.

Use in Special Populations

Pregnant Women

Its use is contraindicated during pregnancy unless the therapeutic benefit is clearly greater than the risk.

Lactating Women

Animal experiments have shown that it can pass into the milk of lactating rats; it is recommended to suspend breastfeeding during the medication period.

Children and Adolescents

There are currently no drug research data available for this population.

Elderly Patients

The dosage regimen must be adjusted strictly in accordance with the physician's guidance.

patic impairment, hypotension, sudden convulsions and other conditions may arise.

For more detailed drug information, please consult the official package leaflet.

Contact Information

If any issues arise, please contact us immediately.

Email:haiousales@gmail.com